PDCD1 and neoplasm: In fact, the accuracy of multiplex immunohistochemistry IHC (mIHC)/immunofluorescence (IF) testing has been shown to be better than that of PD-L1 expression and gene expression characteristics in predicting the response of multiple tumor types to PD-1 checkpoint blockade (16).